According to this latest study, the 2021 growth of Human Coagulation Factor VIII will have significant change from previous year. By the most conservative estimates of global Human Coagulation Factor VIII market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9345.2 million in 2020. Over the next five years the Human Coagulation Factor VIII market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 12040 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VIII market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
- Recombinant Factor VIII
- Plasma-derived Factor VIII
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
Global Human Coagulation Factor VIII Market Growth 2021-2026
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VIII Consumption 2016-2026
2.1.2 Human Coagulation Factor VIII Consumption CAGR by Region
2.2 Human Coagulation Factor VIII Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Sales by Type
2.3.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2016-2021)
2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2016-2021)
2.4 Human Coagulation Factor VIII Segment by Application
2.4.1 Hemophilia A
2.4.2 Spontanous / Trauma
2.4.3 Surgical
2.4.4 Other
2.5 Human Coagulation Factor VIII Sales by Application
2.5.1 Global Human Coagulation Factor VIII Sale Market Share by Application (2016-2021)
2.5.2 Global Human Coagulation Factor VIII Revenue and Market Share by Application (2016-2021)
2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2016-2021)
3 Global Human Coagulation Factor VIII by Company
3.1 Global Human Coagulation Factor VIII Sales Market Share by Company
3.1.1 Global Human Coagulation Factor VIII Sales by Company (2019-2021)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Company (2019-2021)
3.2 Global Human Coagulation Factor VIII Revenue Market Share by Company
3.2.1 Global Human Coagulation Factor VIII Revenue by Company (2019-2021)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Company (2019-2021)
3.3 Global Human Coagulation Factor VIII Sale Price by Company
3.4 Global Manufacturers Human Coagulation Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VIII Product Location Distribution
3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Coagulation Factor VIII by Region
4.1 Global Human Coagulation Factor VIII by Region
4.1.1 Global Human Coagulation Factor VIII Sales by Region
4.1.2 Global Human Coagulation Factor VIII Revenue by Region
4.2 Americas Human Coagulation Factor VIII Sales Growth
4.3 APAC Human Coagulation Factor VIII Sales Growth
4.4 Europe Human Coagulation Factor VIII Sales Growth
4.5 Middle East & Africa Human Coagulation Factor VIII Sales Growth
5 Americas
5.1 Americas Human Coagulation Factor VIII Sales by Country
5.1.1 Americas Human Coagulation Factor VIII Sales by Country (2016-2021)
5.1.2 Americas Human Coagulation Factor VIII Revenue by Country (2016-2021)
5.2 Americas Human Coagulation Factor VIII Sales by Type
5.3 Americas Human Coagulation Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VIII Sales by Region
6.1.1 APAC Human Coagulation Factor VIII Sales by Region (2016-2021)
6.1.2 APAC Human Coagulation Factor VIII Revenue by Region (2016-2021)
6.2 APAC Human Coagulation Factor VIII Sales by Type
6.3 APAC Human Coagulation Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Coagulation Factor VIII by Country
7.1.1 Europe Human Coagulation Factor VIII Sales by Country (2016-2021)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Country (2016-2021)
7.2 Europe Human Coagulation Factor VIII Sales by Type
7.3 Europe Human Coagulation Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Coagulation Factor VIII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VIII Sales by Country (2016-2021)
8.1.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2021)
8.2 Middle East & Africa Human Coagulation Factor VIII Sales by Type
8.3 Middle East & Africa Human Coagulation Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Coagulation Factor VIII Distributors
10.3 Human Coagulation Factor VIII Customer
11 Global Human Coagulation Factor VIII Market Forecast
11.1 Global Human Coagulation Factor VIII Forecast by Region
11.1.1 Global Human Coagulation Factor VIII Forecast by Regions (2021-2026)
11.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Human Coagulation Factor VIII Forecast by Type
11.7 Global Human Coagulation Factor VIII Forecast by Application
12 Key Players Analysis
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Company Information
12.1.2 Shire (Baxter) Human Coagulation Factor VIII Product Offered
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Shire (Baxter) Main Business Overview
12.1.5 Shire (Baxter) Latest Developments
12.2 Bayer
12.2.1 Bayer Company Information
12.2.2 Bayer Human Coagulation Factor VIII Product Offered
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bayer Main Business Overview
12.2.5 Bayer Latest Developments
12.3 CSL
12.3.1 CSL Company Information
12.3.2 CSL Human Coagulation Factor VIII Product Offered
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CSL Main Business Overview
12.3.5 CSL Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Human Coagulation Factor VIII Product Offered
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Grifols
12.5.1 Grifols Company Information
12.5.2 Grifols Human Coagulation Factor VIII Product Offered
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Grifols Main Business Overview
12.5.5 Grifols Latest Developments
12.6 Biogen
12.6.1 Biogen Company Information
12.6.2 Biogen Human Coagulation Factor VIII Product Offered
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Biogen Main Business Overview
12.6.5 Biogen Latest Developments
12.7 Octapharma
12.7.1 Octapharma Company Information
12.7.2 Octapharma Human Coagulation Factor VIII Product Offered
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Octapharma Main Business Overview
12.7.5 Octapharma Latest Developments
12.8 NovoNordisk
12.8.1 NovoNordisk Company Information
12.8.2 NovoNordisk Human Coagulation Factor VIII Product Offered
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 NovoNordisk Main Business Overview
12.8.5 NovoNordisk Latest Developments
12.9 Greencross
12.9.1 Greencross Company Information
12.9.2 Greencross Human Coagulation Factor VIII Product Offered
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Greencross Main Business Overview
12.9.5 Greencross Latest Developments
12.10 Kedrion
12.10.1 Kedrion Company Information
12.10.2 Kedrion Human Coagulation Factor VIII Product Offered
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kedrion Main Business Overview
12.10.5 Kedrion Latest Developments
12.11 BPL
12.11.1 BPL Company Information
12.11.2 BPL Human Coagulation Factor VIII Product Offered
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 BPL Main Business Overview
12.11.5 BPL Latest Developments
12.12 Hualan Bio
12.12.1 Hualan Bio Company Information
12.12.2 Hualan Bio Human Coagulation Factor VIII Product Offered
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Hualan Bio Main Business Overview
12.12.5 Hualan Bio Latest Developments
12.13 RAAS
12.13.1 RAAS Company Information
12.13.2 RAAS Human Coagulation Factor VIII Product Offered
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 RAAS Main Business Overview
12.13.5 RAAS Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Human Coagulation Factor VIII Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Recombinant Factor VIII
Table 3. Major Players of Plasma-derived Factor VIII
Table 4. Global Human Coagulation Factor VIII Sales by Type (2016-2021) & (K Bottles)
Table 5. Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 6. Global Human Coagulation Factor VIII Revenue by Type (2016-2021) & ($ million)
Table 7. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
Table 8. Global Human Coagulation Factor VIII Sale Price by Type (2016-2021)
Table 9. Global Human Coagulation Factor VIII Sales by Application (2016-2021) & (K Bottles)
Table 10. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 11. Global Human Coagulation Factor VIII Value by Application (2016-2021)
Table 12. Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
Table 13. Global Human Coagulation Factor VIII Sale Price by Application (2016-2021)
Table 14. Global Human Coagulation Factor VIII Sales by Company (2019-2021) & (K Bottles)
Table 15. Global Human Coagulation Factor VIII Sales Market Share by Company (2019-2021)
Table 16. Global Human Coagulation Factor VIII Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Human Coagulation Factor VIII Revenue Market Share by Company (2019-2021)
Table 18. Global Human Coagulation Factor VIII Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution and Sales Area
Table 20. Players Human Coagulation Factor VIII Products Offered
Table 21. Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Human Coagulation Factor VIII Sales by Region (2016-2021) (K Bottles)
Table 25. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 26. Global Human Coagulation Factor VIII Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
Table 28. Americas Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 29. Americas Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 30. Americas Human Coagulation Factor VIII Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 32. Americas Human Coagulation Factor VIII Sales by Type (2016-2021) & (K Bottles)
Table 33. Americas Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 34. Americas Human Coagulation Factor VIII Sales by Application (2016-2021) & (K Bottles)
Table 35. Americas Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 36. APAC Human Coagulation Factor VIII Sales by Region (2016-2021) & (K Bottles)
Table 37. APAC Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 38. APAC Human Coagulation Factor VIII Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
Table 40. APAC Human Coagulation Factor VIII Sales by Type (2016-2021) & (K Bottles)
Table 41. APAC Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 42. APAC Human Coagulation Factor VIII Sales by Application (2016-2021) & (K Bottles)
Table 43. APAC Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 44. Europe Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 45. Europe Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 46. Europe Human Coagulation Factor VIII Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 48. Europe Human Coagulation Factor VIII Sales by Type (2016-2021) & (K Bottles)
Table 49. Europe Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 50. Europe Human Coagulation Factor VIII Sales by Application (2016-2021) & (K Bottles)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2016-2021) & (K Bottles)
Table 53. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2016-2021) & (K Bottles)
Table 57. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2016-2021) & (K Bottles)
Table 59. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Human Coagulation Factor VIII
Table 61. Key Application and Potential Industries of Human Coagulation Factor VIII
Table 62. Key Challenges of Human Coagulation Factor VIII
Table 63. Key Trends of Human Coagulation Factor VIII
Table 64. Human Coagulation Factor VIII Distributors List
Table 65. Human Coagulation Factor VIII Customer List
Table 66. Global Human Coagulation Factor VIII Sales Forecast by Region (2021-2026) & (K Bottles)
Table 67. Global Human Coagulation Factor VIII Consumption Market Forecast by Region
Table 68. Global Human Coagulation Factor VIII Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Human Coagulation Factor VIII Sales Forecast by Country (2021-2026) & (K Bottles)
Table 71. Americas Human Coagulation Factor VIII Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Human Coagulation Factor VIII Sales Forecast by Region (2021-2026) & (K Bottles)
Table 73. APAC Human Coagulation Factor VIII Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Human Coagulation Factor VIII Sales Forecast by Country (2021-2026) & (K Bottles)
Table 75. Europe Human Coagulation Factor VIII Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Human Coagulation Factor VIII Sales Forecast by Country (2021-2026) & (K Bottles)
Table 77. Middle East & Africa Human Coagulation Factor VIII Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Human Coagulation Factor VIII Sales Forecast by Type (2021-2026) & (K Bottles)
Table 79. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Human Coagulation Factor VIII Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Human Coagulation Factor VIII Sales Forecast by Application (2021-2026) & (K Bottles)
Table 83. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Human Coagulation Factor VIII Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2021-2026)
Table 86. Shire (Baxter) Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 87. Shire (Baxter) Human Coagulation Factor VIII Product Offered
Table 88. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 89. Shire (Baxter) Main Business
Table 90. Shire (Baxter) Latest Developments
Table 91. Bayer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 92. Bayer Human Coagulation Factor VIII Product Offered
Table 93. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 94. Bayer Main Business
Table 95. Bayer Latest Developments
Table 96. CSL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 97. CSL Human Coagulation Factor VIII Product Offered
Table 98. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 99. CSL Main Business
Table 100. CSL Latest Developments
Table 101. Pfizer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Human Coagulation Factor VIII Product Offered
Table 103. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. Grifols Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 107. Grifols Human Coagulation Factor VIII Product Offered
Table 108. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 109. Grifols Main Business
Table 110. Grifols Latest Developments
Table 111. Biogen Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 112. Biogen Human Coagulation Factor VIII Product Offered
Table 113. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 114. Biogen Main Business
Table 115. Biogen Latest Developments
Table 116. Octapharma Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 117. Octapharma Human Coagulation Factor VIII Product Offered
Table 118. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 119. Octapharma Main Business
Table 120. Octapharma Latest Developments
Table 121. NovoNordisk Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 122. NovoNordisk Human Coagulation Factor VIII Product Offered
Table 123. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 124. NovoNordisk Main Business
Table 125. NovoNordisk Latest Developments
Table 126. Greencross Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 127. Greencross Human Coagulation Factor VIII Product Offered
Table 128. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 129. Greencross Main Business
Table 130. Greencross Latest Developments
Table 131. Kedrion Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 132. Kedrion Human Coagulation Factor VIII Product Offered
Table 133. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 134. Kedrion Main Business
Table 135. Kedrion Latest Developments
Table 136. BPL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 137. BPL Human Coagulation Factor VIII Product Offered
Table 138. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 139. BPL Main Business
Table 140. BPL Latest Developments
Table 141. Hualan Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 142. Hualan Bio Human Coagulation Factor VIII Product Offered
Table 143. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 144. Hualan Bio Main Business
Table 145. Hualan Bio Latest Developments
Table 146. RAAS Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 147. RAAS Human Coagulation Factor VIII Product Offered
Table 148. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 149. RAAS Main Business
Table 150. RAAS Latest Developments
List of Figures
Figure 1. Picture of Human Coagulation Factor VIII
Figure 2. Human Coagulation Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VIII Sales Growth Rate 2016-2026 (K Bottles)
Figure 7. Global Human Coagulation Factor VIII Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Human Coagulation Factor VIII Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Recombinant Factor VIII
Figure 10. Product Picture of Plasma-derived Factor VIII
Figure 11. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 12. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
Figure 13. Human Coagulation Factor VIII Consumed in Hemophilia A
Figure 14. Global Human Coagulation Factor VIII Market: Hemophilia A (2016-2021) & (K Bottles)
Figure 15. Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure 16. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2016-2021) & (K Bottles)
Figure 17. Human Coagulation Factor VIII Consumed in Surgical
Figure 18. Global Human Coagulation Factor VIII Market: Surgical (2016-2021) & (K Bottles)
Figure 19. Human Coagulation Factor VIII Consumed in Other
Figure 20. Global Human Coagulation Factor VIII Market: Other (2016-2021) & (K Bottles)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Figure 22. Global Human Coagulation Factor VIII Revenue Market Share by Application in 2020
Figure 23. Human Coagulation Factor VIII Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2020
Figure 25. Global Human Coagulation Factor VIII Sales Market Share by Regions (2016-2021)
Figure 26. Global Human Coagulation Factor VIII Revenue Market Share by Region in 2020
Figure 27. Americas Human Coagulation Factor VIII Sales 2016-2021 (K Bottles)
Figure 28. Americas Human Coagulation Factor VIII Revenue 2016-2021 ($ Millions)
Figure 29. APAC Human Coagulation Factor VIII Sales 2016-2021 (K Bottles)
Figure 30. APAC Human Coagulation Factor VIII Revenue 2016-2021 ($ Millions)
Figure 31. Europe Human Coagulation Factor VIII Sales 2016-2021 (K Bottles)
Figure 32. Europe Human Coagulation Factor VIII Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Human Coagulation Factor VIII Sales 2016-2021 (K Bottles)
Figure 34. Middle East & Africa Human Coagulation Factor VIII Revenue 2016-2021 ($ Millions)
Figure 35. Americas Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 36. Americas Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 37. Americas Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 38. Americas Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 39. United States Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Human Coagulation Factor VIII Sales Market Share by Region in 2020
Figure 44. APAC Human Coagulation Factor VIII Revenue Market Share by Regions in 2020
Figure 45. APAC Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 46. APAC Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 47. China Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 54. Europe Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 55. Europe Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 56. Europe Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 57. Germany Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 66. Egypt Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Human Coagulation Factor VIII Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Global Human Coagulation Factor VII Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 83
According to our LPI (LP Information) latest study, the global Human Coagulation Factor VII market size was valued at US$ 2232.8 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VII is forecast to a readjusted size of US$ 4339.6 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Human Coagulation Factor VII market. Human Coagulation Factor VII are expected to show stable growt......
Global Human Coagulation Factor VIII Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Human Coagulation Factor VIII market size was valued at US$ 10010 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VIII is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Human Coagulation Factor VIII market. Human Coagulation Factor VIII are expected to show stable grow......
Global D-Dimer Market Research Report 2023
Published: 05-Dec-2023 Price: US 2900 Onwards Pages: 97
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global D-dimer market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- F. Hoffman-La Roche
- Beckman Coulter
- Abbott
- Bio/Data
- Becton Dickinson
- Sysmex
- Siemens Healthcare
- Trinit......
Global Human Coagulation Factor VII Professional Survey Report 2023, Forecast to 2028
Published: 09-Nov-2023 Price: US 3280 Onwards Pages: 104
Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
Global Human Coagulation Factor VII Market Research Report 2023, Forecast to 2028
Published: 09-Nov-2023 Price: US 2680 Onwards Pages: 167
Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
Global Human Coagulation Factor Viii Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 24-Aug-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Human Coagulation Factor Viii market:
According to our latest research, the global Human Coagulation Factor Viii market looks promising in the next 5 years. As of 2022, the global Human Coagulation Factor Viii market was estimated at USD 9757.48 million, and it's anticipated to reach USD 17207.33 million in 2028, with a CAGR of 9.92% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehe......
Global Coagulation Tests Market Insights, Forecast to 2029
Published: 16-Jun-2023 Price: US 4900 Onwards Pages: 109
Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
Global D-dimer Market Insights, Forecast to 2029
Published: 14-Jun-2023 Price: US 4900 Onwards Pages: 107
The global D-dimer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during......
Global Coagulation Tests Market Research Report 2023
Published: 11-Apr-2023 Price: US 2900 Onwards Pages: 86
Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
